The CTC collaborates with the Thoracic Oncology Group of Australasia (TOGA) to initiate and conduct high quality clinical trials research in thoracic cancer in Australia and New Zealand.

In recent years, this has expanded into new trials looking at immunotherapy, targeted therapies for thoracic cancers, and genomic profiling to deliver personalised precision medicine, as well as renewed interest in mesothelioma, and most recently expanding into trials for early-stage lung cancer.

You can read more about the Thoracic Oncology Group of Australasia (TOGA) on their website: 

Thoracic Cancers